Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a complex combination of multiple pain medications and adjuvants spanning different drug classes. It includes: - **Opioid analgesics**: fentanyl, morphine, hydromorphone, and hydrocodone - **Non-opioid analgesics**: acetaminophen, ketorolac, and ibuprofen - **Adjuvant medications**: gabapentin and ketamine This combination would not typically be administered simultaneously as a single formulation due to the overlapping mechanisms, potential for severe respiratory depression, and other serious adverse effects. Each component has distinct properties: - Fentanyl is a synthetic opioid 50-100 times more potent than morphine - Morphine is considered the archetypal opioid painkiller - Hydromorphone has 2-8 times the potency of morphine - Hydrocodone is commonly prescribed for moderate to severe pain - Acetaminophen is a non-opioid analgesic often combined with opioids - Ketorolac is a non-steroidal anti-inflammatory drug (NSAID) - Ibuprofen is another NSAID - Gabapentin is an anticonvulsant with pain-relieving properties - Ketamine is a dissociative anesthetic with analgesic properties
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fentanyl + morphine + hydromorphone + hydrocodone + acetaminophen + ketorolac + gabapentin + ketamine + ibuprofen.